-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Obeticholic Acid in Alcoholic Hepatitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Obeticholic Acid in Alcoholic Hepatitis Drug Details: Obeticholic acid (Ocaliva) is a bile acid analouge....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ulviprubart in Inclusion Body Myositis (IBM)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ulviprubart in Inclusion Body Myositis (IBM) Drug Details: AB-008 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Seladelpar Lysine in Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Seladelpar Lysine in Primary Biliary Cholangitis (Primary Biliary Cirrhosis) Drug Details: Seladelpar lysine (MBX-8025, RWJ-800025)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EP-547 in Uremic (Renal) Pruritus
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.EP-547 in Uremic (Renal) Pruritus Drug Details:EP-547 is under developmant for the treatment of cholestatic pruritus due...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EP-547 in Pruritus
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.EP-547 in Pruritus Drug Details:EP-547 is under developmant for the treatment of cholestatic pruritus due to primary...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EP-547 in Hepatitis C
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.EP-547 in Hepatitis C Drug Details:EP-547 is under developmant for the treatment of cholestatic pruritus due to...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EP-547 in Hepatitis B
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.EP-547 in Hepatitis B Drug Details:EP-547 is under developmant for the treatment of cholestatic pruritus due to...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Bezafibrate + Obeticholic Acid) in Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Bezafibrate + Obeticholic Acid) in Primary Biliary Cholangitis (Primary Biliary Cirrhosis) Drug Details: Fixed-dose combination of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ABC-008 in T-Cell Leukemia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ABC-008 in T-Cell LeukemiaDrug Details:AB-008 is under development for the treatment of inclusion body myositis (IBM),...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – A-3907 in Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. A-3907 in Primary Biliary Cholangitis (Primary Biliary Cirrhosis) Drug Details: A-3907 is under development...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.